Background The disease burden from interstitial lung diseases (ILDs) is thought to be increasing globally, but there is a ...

There is an inconvenient truth that we face unconsciously in our daily lives and business settings. It is the reality that ...

Matt Symonds: You compare AI unfavourably with medicines and aircraft, which can't reach the public without independent pre-deployment approval. The standard reply is that a general-purpose model ...